Study on the development and feasibility of a side effect monitoring program: a preliminary single-arm study

Study on the development and feasibility of a side effect monitoring program: a preliminary single-arm study - Study on the development and feasibility of a side effect monitoring program

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000043919

Enrollment

300

Registered

2021-05-01

Start date

2021-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

1) Hearing before dispensing 2) Data entry into the monitoring system 3) Evaluation of side effect symptoms 4) Medication guidance 5) Entry in medication history

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with a prescription of 31 days or less (in principle) 2) Patients who are expected to continue coming to the pharmacy during the follow-up period (3 months)

Exclusion criteria

Exclusion criteria: 1) Patients receiving home visiting drug management guidance by pharmacists 2) Patients who are unable to answer the questionnaire by themselves 3) First-time visitors

Design outcomes

Primary

Measure	Time frame
Percentage of patients with signs of side effects detected among eligible patients	—

Secondary

Measure	Time frame
1)Self-efficacy of pharmacists in preventing adverse drug reactions 2)Patient satisfaction with treatment	—

Countries

Japan

Contacts

Public ContactMitsuko Onda

Osaka Medical and Pharmaceutical University Faculty of Pharmacy

mitsuko.onda@ompu.ac.jp+81-72-690-1059

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026